OR WAIT null SECS
August 02, 2012
Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
Meticulous system configuration can prevent machines from taking over.
August 01, 2012
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
July 02, 2012
Holistic open learning networks offer a new drug R&D model for improving research outcomes.
June 20, 2012
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.
June 02, 2012
Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
Partnerships between industry and academic medical centers are expanding to meet R&D needs.
Does global development have to entail multiple comparability studies?
May 02, 2012
The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.